Complete Filing Data
Rallybio Corp reported Stockholders Equity of $57.96 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Rallybio Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$9.0M | -$57.8M | -$74.6M | -$66.7M | -$47.0M | -$26.4M |
| Research And Development Expense | $19.6M | $41.5M | $53.5M | $40.7M | $26.9M | $17.6M |
| Other Nonoperating Income Expense | $22.8M | $744.0K | $262.0K | $342.0K | $96.0K | $241.0K |
| Operating Income Loss | -$33.1M | -$60.5M | -$78.9M | -$67.9M | -$45.6M | -$25.3M |
| Operating Expenses | $33.9M | $61.1M | $78.9M | $67.9M | $45.6M | $25.3M |
| Nonoperating Income Expense | $25.0M | $5.0M | $6.4M | $2.3M | $140.0K | $363.0K |
| Income Loss From Equity Method Investments | -$874.0K | -$2.2M | -$2.0M | -$1.1M | -$1.5M | -$1.5M |
| General And Administrative Expense | $14.3M | $19.6M | $25.4M | $27.2M | $18.7M | $7.7M |
| Comprehensive Income Net Of Tax | -$9.0M | -$57.7M | -$74.3M | -$66.9M | -$47.0M | -$26.4M |
| Other Comprehensive Income Loss Net Of Tax | -$50.0K | $53.0K | $229.0K | -$214.0K | $0.00 | |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$8.1M | -$55.5M | -$72.5M | -$65.6M | ||
| Revenues | $858.0K | $636.0K | ||||
| Interest Expense | $0.00 | $10.0K | $49.0K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$65.6M | -$45.5M | -$24.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $16.0M | -$9.7M | -$9.4M | -$11.5M | -$16.2M | -$19.0M | -$18.4M | -$18.6M | -$17.3M | -$18.4M | -$17.6M | -$14.5M | -$10.2M | -$11.1M | -$13.3M | -$7.2M | -$4.9M |
| Research And Development Expense | $4.1M | $6.1M | $5.7M | $8.2M | $12.9M | $12.9M | $13.3M | $13.1M | $11.2M | $12.1M | $10.1M | $7.6M | $5.0M | $6.8M | $9.0M | $5.1M | $3.1M |
| Other Nonoperating Income Expense | $22.5M | $118.0K | $174.0K | $251.0K | $143.0K | $167.0K | $92.0K | $62.0K | $73.0K | $98.0K | $100.0K | $113.0K | $105.0K | -$142.0K | $24.0K | $52.0K | $69.0K |
| Operating Income Loss | -$6.9M | -$10.1M | -$9.7M | -$12.1M | -$17.0M | -$19.8M | -$19.4M | -$20.1M | -$18.4M | -$18.9M | -$17.6M | -$14.3M | -$10.0M | -$10.5M | -$12.8M | -$6.7M | -$4.7M |
| Operating Expenses | $7.1M | $10.3M | $9.9M | $12.4M | $17.3M | $19.8M | $19.4M | $20.1M | $18.4M | $18.9M | $17.6M | $14.3M | $10.0M | $10.5M | $12.8M | $6.7M | $4.7M |
| Nonoperating Income Expense | $22.9M | $641.0K | $818.0K | $1.2M | $1.3M | $1.4M | $1.6M | $1.7M | $1.6M | $623.0K | $370.0K | $210.0K | $117.0K | -$129.0K | $31.0K | $81.0K | $104.0K |
| Income Loss From Equity Method Investments | $0.00 | -$287.0K | -$587.0K | -$637.0K | -$487.0K | -$685.0K | -$648.0K | -$217.0K | -$563.0K | -$133.0K | -$338.0K | -$390.0K | -$332.0K | -$468.0K | -$482.0K | -$526.0K | -$335.0K |
| General And Administrative Expense | $3.0M | $4.2M | $4.2M | $4.1M | $4.4M | $6.9M | $6.1M | $7.0M | $7.2M | $6.8M | $7.5M | $6.7M | $5.0M | $3.7M | $3.8M | $1.6M | $1.6M |
| Comprehensive Income Net Of Tax | $16.0M | -$9.7M | -$9.5M | -$11.2M | -$16.2M | -$19.1M | -$18.3M | -$18.8M | -$17.2M | -$18.4M | -$17.8M | -$14.6M | -$10.2M | -$11.1M | -$13.3M | -$7.2M | -$4.9M |
| Other Comprehensive Income Loss Net Of Tax | $7.0K | -$30.0K | -$21.0K | $240.0K | $0.00 | -$86.0K | $64.0K | -$211.0K | $153.0K | -$63.0K | -$249.0K | -$122.0K | $0.00 | $0.00 | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $16.0M | -$9.4M | -$8.9M | -$10.8M | -$15.7M | -$18.3M | -$17.7M | -$18.4M | -$16.8M | -$18.2M | -$17.2M | -$14.1M | |||||
| Revenues | $212.0K | $212.0K | $212.0K | $299.0K | $299.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.0K | $13.0K | $12.0K | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$18.2M | -$17.2M | -$14.1M | -$9.9M | -$10.7M | -$12.8M | -$6.6M | -$4.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $58.0M | $61.7M | $106.2M | $169.3M | $175.6M | $136.0M | $16.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $31.4M | $13.9M | $24.5M | $57.0M | $175.3M | $140.2M | |
| Marketable Securities Unrealized Gain Loss | -$50.0K | $53.0K | $229.0K | -$214.0K | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$302.0M | -$293.0M | -$235.2M | -$160.7M | -$94.0M | -$47.0M | |
| Property Plant And Equipment Net | $23.0K | $115.0K | $246.0K | $385.0K | $511.0K | $287.0K | |
| Prepaid Expense And Other Assets Current | $6.5M | $2.3M | $4.9M | $10.5M | $5.5M | $1.0M | |
| Liabilities Current | $4.2M | $6.2M | $9.3M | $10.7M | $6.6M | $5.8M | |
| Liabilities And Stockholders Equity | $62.3M | $68.1M | $115.6M | $180.4M | $182.2M | $141.9M | |
| Liabilities | $4.3M | $6.5M | $9.4M | $11.1M | $6.6M | $5.9M | |
| Common Stock Value | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | |
| Cash And Cash Equivalents At Carrying Value | $31.4M | $13.9M | $24.5M | $57.0M | $175.3M | $140.2M | |
| Assets Current | $61.3M | $67.8M | $114.8M | $179.5M | $180.9M | $141.3M | |
| Assets | $62.3M | $68.1M | $115.6M | $180.4M | $182.2M | $141.9M | |
| Accrued Liabilities Current | $3.8M | $5.0M | $8.1M | $9.4M | $5.9M | $4.3M | |
| Accounts Payable Current | $126.0K | $278.0K | $976.0K | $1.1M | $603.0K | $1.6M | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Operating Lease Right Of Use Asset | $175.0K | $152.0K | $346.0K | $524.0K | $0.00 | ||
| Operating Lease Liability Current | $94.0K | $154.0K | $219.0K | $181.0K | $0.00 | ||
| Marketable Securities Current | $23.4M | $51.6M | $85.4M | $112.0M | $0.00 | ||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | $239.0K | $30.0K | $805.0K | $310.0K | |||
| Amortization Of Debt Discount Premium | -$573.0K | -$1.6M | -$3.1M | -$435.0K | $0.00 | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $18.0K | $68.0K | $15.0K | -$214.0K | $0.00 | ||
| Operating Lease Liability Noncurrent | $82.0K | $0.00 | $173.0K | $374.0K | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $17.5M | -$10.6M | -$32.5M | -$118.4M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $19.5M | ||||||
| Contract With Customer Liability Current | $212.0K | $848.0K | $0.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$118.4M | $35.1M | $120.8M | ||||
| Other Accrued Liabilities Noncurrent | $0.00 | $32.0K | $12.0K | ||||
| Contract With Customer Liability Noncurrent | $0.00 | $212.0K | $0.00 | ||||
| Offering Costs In Accounts Payable And Accrued Expenses | $0.00 | $139.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $63.0M | $46.0M | $54.1M | $70.8M | $80.0M | $89.2M | $123.6M | $139.3M | $155.2M | $131.9M | $147.9M | $163.0M | $186.5M | $112.7M | $123.3M | $146.3M | $153.2M | -$24.1M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $32.1M | $9.4M | $14.8M | $25.3M | $16.7M | $19.3M | $19.2M | $32.6M | $39.5M | $51.7M | $60.8M | $81.4M | |||||||||
| Marketable Securities Unrealized Gain Loss | $7.0K | -$30.0K | -$21.0K | $240.0K | $0.00 | -$86.0K | $64.0K | -$211.0K | $153.0K | -$63.0K | -$249.0K | -$122.0K | $0.00 | $0.00 | $0.00 | ||||||
| Retained Earnings Accumulated Deficit | -$296.1M | -$312.2M | -$302.5M | -$282.0M | -$270.5M | -$254.3M | -$215.0M | -$196.6M | -$178.0M | -$144.5M | -$126.1M | -$108.5M | -$81.6M | -$71.4M | |||||||
| Property Plant And Equipment Net | $26.0K | $61.0K | $87.0K | $145.0K | $177.0K | $211.0K | $282.0K | $308.0K | $346.0K | $424.0K | $468.0K | $499.0K | $445.0K | $306.0K | |||||||
| Prepaid Expense And Other Assets Current | $7.3M | $4.5M | $2.9M | $3.1M | $2.8M | $4.4M | $11.0M | $9.0M | $10.9M | $10.0M | $6.9M | $6.4M | $5.4M | $5.7M | |||||||
| Liabilities Current | $4.5M | $5.0M | $3.9M | $8.2M | $12.2M | $10.1M | $9.4M | $8.1M | $6.8M | $11.3M | $7.3M | $5.8M | $7.3M | $7.4M | |||||||
| Liabilities And Stockholders Equity | $67.7M | $51.0M | $58.0M | $79.0M | $92.4M | $99.4M | $133.2M | $147.6M | $162.3M | $143.7M | $155.6M | $169.4M | $193.9M | $120.1M | |||||||
| Liabilities | $4.6M | $5.0M | $3.9M | $8.2M | $12.4M | $10.2M | $9.6M | $8.3M | $7.1M | $11.7M | $7.8M | $6.3M | $7.4M | $7.4M | |||||||
| Common Stock Value | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $536.0K | |||||||
| Cash And Cash Equivalents At Carrying Value | $32.1M | $9.4M | $14.8M | $25.3M | $16.7M | $19.3M | $19.2M | $32.6M | $39.5M | $51.7M | $60.8M | $81.4M | $187.0M | $112.7M | |||||||
| Assets Current | $66.6M | $50.3M | $57.4M | $78.2M | $91.4M | $98.5M | $132.4M | $146.8M | $161.3M | $142.4M | $154.3M | $167.8M | $192.4M | $118.4M | |||||||
| Assets | $67.7M | $51.0M | $58.0M | $79.0M | $92.4M | $99.4M | $133.2M | $147.6M | $162.3M | $143.7M | $155.6M | $169.4M | $193.9M | $120.1M | |||||||
| Accrued Liabilities Current | $3.7M | $4.2M | $2.5M | $6.3M | $9.5M | $9.4M | $8.7M | $7.2M | $5.8M | $10.3M | $6.5M | $4.6M | $4.7M | $4.8M | |||||||
| Accounts Payable Current | $269.0K | $119.0K | $400.0K | $583.0K | $1.2M | $470.0K | $464.0K | $689.0K | $782.0K | $828.0K | $633.0K | $1.1M | $2.6M | $2.6M | |||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Operating Lease Right Of Use Asset | $198.0K | $51.0K | $102.0K | $201.0K | $250.0K | $299.0K | $388.0K | $434.0K | $479.0K | $569.0K | $613.0K | $657.0K | |||||||||
| Operating Lease Liability Current | $90.0K | $58.0K | $116.0K | $230.0K | $226.0K | $223.0K | $217.0K | $213.0K | $197.0K | $165.0K | $150.0K | $148.0K | |||||||||
| Marketable Securities Current | $27.2M | $36.3M | $39.7M | $49.8M | $71.9M | $74.9M | $102.2M | $105.3M | $110.9M | $80.7M | $86.6M | $80.0M | |||||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | $626.0K | $413.0K | $0.00 | $431.0K | $568.0K | $304.0K | $102.0K | $0.00 | $217.0K | $244.0K | $227.0K | $415.0K | $1.0M | $1.4M | |||||||
| Amortization Of Debt Discount Premium | -$210.0K | -$539.0K | -$895.0K | $36.0K | $0.00 | ||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $24.0K | $17.0K | $47.0K | $169.0K | -$71.0K | -$71.0K | -$208.0K | -$272.0K | -$61.0K | -$434.0K | -$371.0K | -$122.0K | |||||||||
| Operating Lease Liability Noncurrent | $108.0K | $0.00 | $58.0K | $116.0K | $211.0K | $266.0K | $321.0K | $428.0K | $478.0K | $517.0K | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $876.0K | -$5.2M | -$17.4M | ||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $51.7M | $60.8M | $81.4M | $175.3M | $187.0M | $112.7M | $127.7M | $140.2M | $148.0M | $153.6M | |||||||||||
| Contract With Customer Liability Current | $424.0K | $636.0K | $848.0K | $1.1M | $1.2M | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$17.4M | -$93.9M | -$12.5M | ||||||||||||||||||
| Other Accrued Liabilities Noncurrent | $0.00 | $0.00 | $0.00 | $35.0K | $27.0K | ||||||||||||||||
| Contract With Customer Liability Noncurrent | $0.00 | $0.00 | $0.00 | $195.0K | |||||||||||||||||
| Offering Costs In Accounts Payable And Accrued Expenses |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $5.3M | $8.0M | $10.9M | $9.5M | $3.6M | $704.0K |
| Payments To Acquire Interest In Joint Venture | $1.5M | $2.0M | $2.3M | $300.0K | $2.0M | $1.9M |
| Net Cash Provided By Used In Operating Activities | -$29.8M | -$49.3M | -$60.3M | -$57.3M | -$45.5M | -$22.0M |
| Net Cash Provided By Used In Investing Activities | $47.3M | $33.5M | $27.7M | -$112.2M | -$2.3M | -$2.1M |
| Net Cash Provided By Used In Financing Activities | $16.0K | $5.2M | $143.0K | $51.1M | $83.0M | $144.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.0M | -$2.7M | -$5.8M | $4.6M | $4.5M | -$434.0K |
| Increase Decrease In Accrued Liabilities | -$1.1M | -$3.3M | -$1.4M | $3.2M | $1.7M | $963.0K |
| Increase Decrease In Accounts Payable | -$152.0K | -$698.0K | -$99.0K | $487.0K | -$976.0K | $723.0K |
| Payments To Acquire Marketable Securities | $17.7M | $48.9M | $108.4M | $201.3M | $0.00 | |
| Payments Of Stock Issuance Costs | $0.00 | $268.0K | $139.0K | $693.0K | $3.2M | $319.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $46.5M | $84.4M | $138.3M | $89.5M | $0.00 | |
| Proceeds From Issuance Of Common Stock | $0.00 | $5.4M | $0.00 | $0.00 | $145.2M | |
| Payments To Acquire Property Plant And Equipment | $0.00 | $12.0K | $54.0K | $333.0K | $137.0K | |
| Increase Decrease In Contract With Customer Liability | -$848.0K | $1.1M | $0.00 | |||
| Proceeds From Stock Plans | $16.0K | $62.0K | $282.0K | $217.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $1.9M | $2.1M | $3.0M | $2.1M | $522.0K |
| Payments To Acquire Interest In Joint Venture | $1.0M | $750.0K | $750.0K | $0.00 | $500.0K |
| Net Cash Provided By Used In Operating Activities | -$10.2M | -$15.5M | -$18.8M | -$13.7M | -$11.9M |
| Net Cash Provided By Used In Investing Activities | $11.1M | $10.3M | $1.5M | -$80.2M | -$562.0K |
| Net Cash Provided By Used In Financing Activities | $0.00 | $0.00 | -$139.0K | $0.00 | $0.00 |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $506.0K | -$537.0K | $340.0K | $794.0K | -$61.0K |
| Increase Decrease In Accrued Liabilities | -$2.5M | $1.3M | -$3.6M | -$1.4M | -$1.2M |
| Increase Decrease In Accounts Payable | $122.0K | -$506.0K | -$295.0K | $447.0K | $1.4M |
| Payments To Acquire Marketable Securities | $5.9M | $10.7M | $29.3M | $80.1M | $0.00 |
| Payments Of Stock Issuance Costs | $0.00 | $139.0K | $0.00 | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $18.0M | $21.8M | $31.5M | $0.00 | |
| Proceeds From Issuance Of Common Stock | |||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $36.0K | $62.0K | ||
| Increase Decrease In Contract With Customer Liability | -$212.0K | $0.00 | |||
| Proceeds From Stock Plans |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.59 | -$10.61 | -$1.84 | -$2.09 | -$1.84 | -$1.52 |
| Weighted Average Number Of Shares Outstanding Basic | 5.6M | 5.4M | 40.4M | 31.8M | 25.5M | |
| Weighted Average Number Of Diluted Shares Outstanding | 5.6M | 5.4M | 40.4M | 31.8M | 25.5M | |
| Earnings Per Share Basic | $-1.59 | $-10.61 | $-1.84 | $-2.09 | $-1.84 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 5.3M | 5.2M | 37.8M | 37.8M | 32.1M | 23.4M |
| Common Stock Shares Outstanding | 5.3M | 5.2M | 37.8M | 37.8M | 32.1M | 23.4M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 25.5M | 17.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.36 | -$0.22 | -$0.21 | -$0.26 | -$0.37 | -$0.47 | -$0.45 | -$0.46 | -$0.43 | -$0.60 | -$0.57 | -$0.48 | -$0.37 | -$0.49 | -$0.60 | -$0.32 | -$1.85 | |
| Weighted Average Number Of Shares Outstanding Basic | 45.1M | 44.8M | 44.8M | 44.6M | 44.1M | 40.8M | 40.5M | 40.4M | 40.2M | 30.8M | 30.6M | 30.3M | 27.5M | 22.6M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 45.1M | 44.8M | 44.8M | 44.6M | 44.1M | 40.8M | 40.5M | 40.4M | 40.2M | 30.8M | 30.6M | 30.3M | 27.5M | 22.6M | ||||
| Earnings Per Share Basic | $0.36 | $-0.22 | $-0.21 | $-0.26 | $-0.37 | $-0.47 | $-0.45 | $-0.46 | $-0.43 | $-0.60 | $-0.57 | $-0.48 | $-0.37 | $-0.49 | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Issued | 41.9M | 41.7M | 41.6M | 41.5M | 41.5M | 37.8M | 37.8M | 37.8M | 37.7M | 32.1M | 32.1M | 32.1M | 32.1M | 5.7M | 706.7K | |||
| Common Stock Shares Outstanding | 41.9M | 41.7M | 41.6M | 41.5M | 41.5M | 37.8M | 37.8M | 37.8M | 37.7M | 32.1M | 32.1M | 32.1M | 32.1M | 5.7M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 30.3M | 27.5M | 4.0M | 22.2M | 22.1M | 2.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Interest And Other Income | $2.2M | $4.2M | $6.1M | $2.0M | $54.0K | $171.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.3M | $8.0M | $10.9M | $9.5M | $3.6M | $704.0K |
| Depreciation And Amortization | $92.0K | $131.0K | $150.0K | $167.0K | $109.0K | $62.0K |
| Additional Paid In Capital | $359.9M | $354.6M | $341.4M | $330.2M | $269.6M | $183.0M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $16.0K | $62.0K | $282.0K | $217.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $13.0K | ||||
| Gains Losses On Investment In Joint Venture | -$1.5M | -$1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest And Other Income | $462.0K | $523.0K | $644.0K | $986.0K | $1.1M | $1.3M | $1.5M | $1.6M | $1.5M | $525.0K | $270.0K | $97.0K | $12.0K | $13.0K | $17.0K | $42.0K | $47.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.0M | $1.6M | $1.9M | $2.0M | $1.9M | $2.1M | $2.6M | $2.7M | $3.0M | $2.5M | $2.6M | $2.1M | $1.1M | $539.0K | $522.0K | ||
| Depreciation And Amortization | $28.0K | $35.0K | $39.0K | $42.0K | $23.0K | ||||||||||||
| Additional Paid In Capital | $359.2M | $358.1M | $356.5M | $352.6M | $350.6M | $343.5M | $338.8M | $336.2M | $333.3M | $276.9M | $274.3M | $271.7M | $268.1M | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $10.0K | $44.0K | $209.0K | ||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $8.0K | $0.00 | ||||||||||||||
| Gains Losses On Investment In Joint Venture | -$390.0K | -$482.0K |
Most recent annual filing with the SEC: March 16, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.